Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Hirosumi Miyakawa"'
Autor:
Mizuki Ogawa, Yuki Kojima, Mio Ishizaka, Hirosumi Miyakawa, Huai-hsun Hsu, Yuichi Miyagawa, Naoyuki Takemura
Publikováno v:
Open Veterinary Journal, Vol 13, Iss 5, Pp 604-612 (2023)
Background: Plasma N-terminal pro-atrial natriuretic peptide (NT-proANP) and plasma N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations may be affected by the hydration status. Aim: This study aimed to evaluate the effect of dehydrat
Externí odkaz:
https://doaj.org/article/fece11f3e8144c3eac0c6409ab0942a4
Publikováno v:
Journal of Advanced Veterinary and Animal Research, Vol 9, Iss 3, Pp 440-446 (2022)
Objective: The treatment of syncope depends largely on its possible etiology. Therefore, identifying the cause of syncope is very important in treatment planning. Herein, we report an etiology of syncope caused by pulmonary hypertension (PH) associat
Externí odkaz:
https://doaj.org/article/4945ae082d554e829b1b5934c5e82e83
Autor:
Mizuki Ogawa, Haruka Ogi, Hirosumi Miyakawa, Huai-Hsun Hsu, Yuichi Miyagawa, Naoyuki Takemura
Publikováno v:
Veterinary World, Vol 15, Iss 8, Pp 2072-2083 (2022)
Background and Aim: Electrocardiography (ECG) is an adjunct for cardiac enlargement diagnosis. However, its efficacy in assessing left cardiac remodeling (left atrial and left ventricular enlargement) in dogs with myxomatous mitral valve disease (MMV
Externí odkaz:
https://doaj.org/article/2099bdd4c0414d40ab733977f12999db
Autor:
Mizuki Ogawa, Saran Fatim Kaba, Hirosumi Miyakawa, Huai-hsun Hsu, Yuichi Miyagawa, Naoyuki Takemura
Publikováno v:
Open Veterinary Journal, Vol 12, Iss 4, Pp 489-494 (2022)
Background: A patch Holter electrocardiograph (P-Holter) is cordless, making it lightweight unlike the conventional Holter electrocardiograph (C-Holter). A P-Holter can also take continuous measurements. For up to 14 days without replacing the batter
Externí odkaz:
https://doaj.org/article/9e4f88f5fa544d2483ca3830b3801142
Autor:
Hirosumi Miyakawa, Huai‐Hsun Hsu, Mizuki Ogawa, Ryota Akabane, Yuichi Miyagawa, Naoyuki Takemura
Publikováno v:
Journal of Veterinary Internal Medicine, Vol 35, Iss 5, Pp 2296-2305 (2021)
Abstract Background Fibroblast growth factor (FGF)‐23 is increased first in the sequence of changes associated with chronic kidney disease (CKD)‐mineral and bone disorder. Thus, its measurement may serve as a predictive indicator of incident hype
Externí odkaz:
https://doaj.org/article/11746172c66a4b588b60be230a90fe79
Autor:
Huai-hsun Hsu, Shion Ueno, Hirosumi Miyakawa, Mizuki Ogawa, Yuichi Miyagawa, Naoyuki Takemura
Publikováno v:
Journal of Feline Medicine and Surgery. 24:e70-e75
Objectives This study aimed to define the prevalence of upper urolithiasis in cats with chronic kidney disease (CKD) in a referral population, and to compare urinary calcium:creatinine ratio (UCa:Cr), and total and ionised calcium between cats with C
Autor:
Masayoshi Nagakawa, Yuichi Miyagawa, Ryota Akabane, Atsushi Sakatani, Hirosumi Miyakawa, Naoyuki Takemura, Mizuki Ogawa
Publikováno v:
Research in Veterinary Science. 133:106-110
The effects of different doses of orally administered sildenafil on pulmonary haemodynamics in dogs with pulmonary hypertension (PH) have not been documented in an invasive and quantitative manner. In this study, we examined the effects of oral silde
Autor:
Hirosumi Miyakawa, Mizuki Ogawa, Ryota Akabane, Naoyuki Takemura, Yuichi Miyagawa, Atsushi Sakatani, Masayoshi Nagakawa
Publikováno v:
Research in Veterinary Science. 133:150-156
Renal proteinuria is associated with promoted renal dysfunction and a shorter survival period in dogs with chronic kidney disease (CKD). Renin angiotensin- aldosterone system inhibitors are primarily used to treat renal proteinuria. In this retrospec
Autor:
Hirosumi Miyakawa, Tsuyoshi Tokuriki, Jin Shigemoto, Masayoshi Nagakawa, Yukari Koyama, Noriko Toda, Yuichi Miyagawa, Mizuki Ogawa, Ryota Akabane, Atsushi Sakatani, Shoma Mikawa, Haruka Ogi, Naoyuki Takemura
Publikováno v:
Journal of Veterinary Cardiology. 30:92-99
Introduction/Objectives The American College of Veterinary Internal Medicine (ACVIM) guidelines suggest that pimobendan should be initiated in dogs which meet all criteria of stage B2 myxomatous mitral valve disease (MMVD): murmur intensity ≥ 3/6,
Autor:
Hirosumi Miyakawa, Naoyuki Takemura, Ryota Akabane, Yuichi Miyagawa, Mizuki Ogawa, Masayoshi Nagakawa
Publikováno v:
The Journal of Veterinary Medical Science
Serum cystatin C levels (CysC) are used in human medicine to document progressive kidney failure. Although CysC are not thought to be useful for the diagnosis of kidney dysfunction in dogs, there has been no specific consideration of body weight as a